Sponsor:
Aerie Pharmaceuticals
Code:
NCT05769153
Conditions
Neovascular Age-related Macular Degeneration (nAMD)
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
AR-14034 SR implant lower dose
Aflibercept Injection
Sham procedure
AR-14034 SR implant higher dose
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations